A genome-wide screen for asthma and atopy susceptibility alleles conducted in the Hutterites, a founder population of European descent, reported evidence of linkage with a short tandem repeat polymorphism (STRP) within the type I interferon (IFN) gene cluster on chromosome 9p21. The goal of this study was to identify variation within the IFN gene cluster that influences susceptibility to asthma and atopic phenotypes. We screened approximately 25 kb of sequence, including the flanking sequence of all 15 functional genes and the single coding exon in 12, in Hutterites representing different IFNA-STRP genotypes. We identified 78 polymorphisms, and genotyped 40 of these (in 14 genes) in a large Hutterite pedigree. Modest associations (0.003oPo0.05) with asthma, bronchial hyper-responsiveness (BHR), and atopy were observed with individual variants or genes, spanning the entire 400 kb region. However, pairwise combinations of haplotypes between genes showed highly significant associations with different phenotypes (Po10
Introduction
Asthma is a complex disease that affects nearly 300 million individuals worldwide. 1 The rising incidence of asthma and atopic disorders over the past decades attests to the importance of environmental and lifestyle factors in disease risk, [2] [3] [4] although family and twin studies support a strong genetic component to both. 5, 6 Allergic sensitization to one or more allergens (atopy) is one of the most important risk factors for asthma, as are family history and early life environmental exposures. [7] [8] [9] [10] [11] To identify genes that might be involved in asthma and atopy pathogenesis, we conducted a genome-wide screen in a founder population, the Hutterites. 12 In this earlier study, a short tandem repeat polymorphism (IFNA-STRP) on the short arm of chromosome 9 showed evidence of linkage to asthma using the transmission disequilibrium test (TDT) in a large Hutterite pedigree (P ¼ 2.5 Â 10
À5
). More recently, using a case-control test, 13 this STRP was also associated with asthma (P ¼ 4.9 Â 10
À3
). Both tests indicated that the 150 and 156 base pair (bp) alleles were over-represented and the 154 and 158 bp alleles under-represented in affected individuals. The IFNA-STRP lies within the type I IFN gene cluster, which spans approximately 400 kb on chromosome 9p22. The region consists of 15 functional IFN genes, including 13 IFN-a genes, one IFN-o gene, and one IFN-b gene, in addition to 11 IFN pseudogenes. 14 All IFN genes consist of a single exon and are highly homologous to each other. On the whole, the coding regions of the 13 IFN-a genes display greater than 80% nucleotide identity to each other, while the IFN-o gene displays approximately 60% identity to any of the IFN-a genes, and the IFN-b gene is about 40% identical to the rest of the cluster. 15 The type I interferons are pleiotropic cytokines with important roles in inflammation, immunoregulation, and T cell responses, 16 making them outstanding candidates for asthma and atopy susceptibility genes. The potent antiviral properties of type I interferons have long been recognized, 17, 18 and viral infections, such as respiratory syncytial virus (RSV) and rhinovirus (RV), may be early life triggers of asthma. [19] [20] [21] [22] More recently, however, additional roles for interferons have been described, including skewing the adaptive immune system toward a Th1 profile 23 and the induction of apoptosis. 24 Furthermore, reduced levels of IFN-a in patients with the Th2-associated diseases asthma and atopy have been reported, 25, 26 and treatment with IFN-a therapy improves clinical symptoms in some patients. [27] [28] [29] [30] Thus, we hypothesized that variation in one or more of these genes could modulate expression levels or function of the type I interferons and, as a result, influence the development or course of asthma and atopic diseases.
The goal of this study was to identify polymorphisms in the 15 IFN genes and their flanking sequences, genotype selected single-nucleotide polymorphisms (SNPs) in a sample of 4700 Hutterites who are well characterized with respect to asthma and atopy phenotypes, and test the hypothesis that variation in the type I IFN gene cluster contributes to asthma and atopy susceptibility.
Materials and methods

Subjects
The Hutterites are a founder population of European descent. The 760 Hutterites in our study population belong to a single 13-generation, 1623 member pedigree and live on nine communal farms (colonies) in South Dakota. 31 The Hutterites in our studies can be traced back to 62 Hutterite ancestors who lived in the early 1700's to early 1800's. 32 The relatively small number of founders minimizes genetic heterogeneity in the population, and their communal, farming lifestyle ensures that all members are exposed to a relatively uniform environment. In particular, all meals are prepared and eaten in a common kitchen and dining room, smoking is prohibited, and exposures to allergens are relatively uniform among the colonies. Overall, the similar environmental exposure should enhance the role of genetic variation on disease risk in this population. 33 We visited nine Hutterite colonies that were chosen based both on their location and to represent the different lines of Hutterite colony descent. 32 Nearly all Hutterites over the age of 5 who were present in the colonies on the days of our visits participated in the study. The mean age of participants was 30.1 years (s.d. 18.2 years; range 6-89), and mean inbreeding coefficient of the individuals in this sample is 0.034 (s.d. 0.015), slightly greater than that of first cousins once removed. 12 These studies were approved by the Institutional Review Boards at the University of Chicago and the University of South Dakota.
Evaluation of phenotypes Details of our protocols have been described previously; 12, 34, 35 the clinical characteristics of the study population are shown in Table 1 . Briefly, 660 subjects were phenotyped. Individuals were considered to have asthma if they (1) were bronchial hyper-responsive (X20% decrease in baseline forced expiratory volume in one second [FEV 1 ] after inhalation of p25 mg methacholine/ml); (2) reported the presence of two or three symptoms (wheeze, cough, shortness of breath); and (3) had a doctor's diagnosis of asthma. Eighty-three individuals met this definition of asthma, which was in general mild, as both oral steroid use and hospitalizations were rare. Because during field trips to Hutterite colonies, we identified cases of undiagnosed asthma and because many Hutterites did not reliably recall past asthma symptoms (some did not understand the word 'wheeze' because it is not in the German language), we also used a more relaxed diagnosis of asthma, referred to here as 'possible asthma' (N ¼ 236), that included additional individuals with bronchial hyper-responsiveness (BHR) (N ¼ 80) or at least two symptoms (N ¼ 73) or both (N ¼ 83). Four hundred twenty-four individuals who had neither symptoms nor BHR were considered as controls.
Atopy (allergic sensitization) was evaluated by measuring specific IgE response by skin prick test (SPT) to 14 common allergens: house dust mites (HDM) (Dermatophagoides pteronyssinus, Dermatophagoides farinae), cockroaches (Blattela germanica, Periplaneta Americana), molds (Alternaria alternate, Cladosporium herbarum, Aspergillus fumigatus), pollens (Lolium perenne, Ambrosia artemisifolia, Artemisia vulgaris, Quercus alba, Betula verrucosa), and animal danders (Felis domesticus, Canis familiaris). Because few Hutterites were sensitized to animal danders (Table 1) , we did not analyze that as a separate category. All tests included a negative (saline solution) and a positive (histamine) control. A positive ( þ ) SPT was defined as equivalent to a 3 mm or greater wheal diameter resulting from the corrected reaction area (subtraction of saline control). Analyses were performed for five atopy categories: þ SPT to one or more allergen group (n ¼ 311), þ SPT to HDM (n ¼ 158), þ SPT to cockroach (n ¼ 150), þ SPT to mold (n ¼ 75), and þ SPT to tree/pollen (n ¼ 158). Type I interferons and asthma and atopy A Chan et al
Polymorphism discovery
We screened DNA from 12 Hutterites who were selected because they were heterozygous at the IFNA-STRP locus and were relatively distantly related within the Hutterite pedigree. Two siblings (individuals 8 and 12 in Figure 1 ) were included because they carried all four parental chromosomes at the IFN 'locus'. Ten of the individuals in our screening set were unaffected controls, one (individual 5 in Figure 1 ) was of unknown affection status, and one (individual 12 in Figure 1 ) had BHR. These 12 individuals carried all four of the IFNA-STRP alleles in different combinations. After these studies were completed, we re-sequenced the exons of three genes (IFNA1, IFNA8, and IFNA21) in an additional 36 individuals (18 with asthma symptoms, BHR, or both and 18 unaffected) who were also relatively unrelated to each other and to the 12 individuals in the screening set, to confirm that nonsynonymous (ns)SNPs that were present in dbSNP but not in our 12-person screening set were, in fact, not present in the Hutterites. Our goal was to identify at least one polymorphism each in the 5 0 and 3 0 flanking regions of the coding exon of each gene with a minor allele frequency (MAF) 40.10 and all polymorphisms within exons. We used this cutoff because we had already detected linkage to this region by the TDT. We assumed, therefore, that the susceptibility allele(s) had to be relatively common to generate to this signal. Because of the high homology between the exons of the IFN genes, we designed pairs of primers that were complementary to the upstream and downstream regions of each gene to amplify both flanking sequences and the exons. Lastly, primers were designed whenever possible to amplify regions containing known and validated polymorphisms. A description of all variants, primer sequences and PCR conditions is described in Table S1 .
Screening for polymorphisms in the Hutterites was performed by denaturing high-performance liquid chromatography (DHPLC). 36 DHPLC detects polymorphisms by separating heteroduplex from homoduplex DNA fragments under partial denaturing conditions. Homoduplex fragments show up as a single peak, while heteroduplex fragments show up as a doublet. Prior to DHPLC, PCR products were denatured at 941C and then re-annealed by gradual cooling to 651C over 30 min to allow the formation of homoduplex or heteroduplex DNA molecules. All samples were then compared by DHPLC using either a Varian Chromatography System (Walnut Creek, CA, USA) or a WAVE s DNA Fragment Analysis System (Transgenomic, Inc., San Jose, CA, USA).
PCR products from samples with variant DHPLC patterns were sequenced to determine the underlying sequence variation, using BigDye s terminator chemistry (BigDye s Terminator v3.1 Cycle Sequencing Kit, Applied Biosystems, Foster City, CA, USA). Products were analyzed on an ABI 3100 sequencer. The primers used for sequencing were the same as those used for PCR. The sequences were analyzed using Sequenchert version 3.1.1 (Gene Codes, Ann Arbor, MI, USA). 1  76  2  3  4  5  6  7  8  10  11  12  15  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  16  33  34  35  36  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  37  38  39  9  13  14  77  78 IFNA-STRP Table S1 .
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Genotyping
We genotyped in 760 Hutterites all of the polymorphisms present in the 12-person screening set that were amenable to one of the genotyping platforms used in our laboratory (see Table S1 for a description of these methods). Because of the high sequence similarity between these genes, we could only genotype 40 polymorphisms (36 SNPs and 4 insertion/deletions (in/dels)). However, nearly all of the untyped SNPs identified in the Hutterites were in strong LD with a typed SNP in the screening set. The 760 Hutterites included the 660 individuals with phenotypes described in Table 1 . Genotypes were checked for Mendelian errors using PedCheck. 37 Hardy-Weinberg proportions were checked using a method designed for large pedigrees. 38 Analysis of individual variants We tested the individual variants for asthma and atopy phenotypes using a case-control test designed specifically for large pedigrees. 13 This method takes into account both the relatedness between individuals and their inbreeding, and is more powerful than the TDT in the Hutterites. 13 We corrected for multiple comparisons using the Bonferroni correction for the number of genes tested (N ¼ 14) and considered Po0.0036 (0.05/14) to be significant. We did not correct for the number of phenotypes (3 asthma and 5 atopy phenotypes) in any analyses because these phenotypes are highly correlated and the Bonferroni correction is overly conservative in such cases.
Haplotype analysis
Haplotypes comprised of polymorphisms within each gene were constructed manually by direct observation of alleles segregating in families. Phase was assigned to each parental chromosome based on the genotype data in families, which were often three generations. Haplotypes were not constructed in situations in which phase could not be unambiguously determined. These gene-specific haplotypes were tested for association using the casecontrol test to determine whether variation within each gene contributes to risk. In two genes (IFNA14 and IFNA10), we were only able to genotype one SNP. As a result, we included these individual SNPs in the haplotypes of their nearest neighboring genes (IFNA17 and IFNA16, respectively). For these individual analyses of 12 'genes', we used Po0.0041 (0.05/12) as the cutoff for significance at the 5% level.
During the construction of haplotypes within each gene, we kept track of the parental origin of each haplotype whenever possible. This allowed us to construct haplotypes between all pairwise combinations of genes, which were also tested for association using the case-control test. The latter analyses were performed to determine if combinations of genes contributed to risk; here we used a critical P-value of o0.00055 to account for the 91 pairwise comparisons (0.05/91).
Analysis of linkage disequilibrium
We assessed linkage disequilibrium (LD) between markers by estimating r 2 using LDplotter (http://innateimmunity.net/ IIPGA2/Bioinformatics/pbtoldplotform).
Results
Sequence variation and patterns of LD
We screened approximately 25 kb of DNA, including flanking sequence in all 15 genes and the coding exon in 12 of these genes. Overall, we identified 72 SNPs and six in/dels, including at least one polymorphism in the flanking region of each gene (Table S1 ). Twelve exonic polymorphisms included four synonymous SNPs, seven nsSNPs, and one frameshift (fs) SNP (Figure 1) . Four of the exonic polymorphisms were previously reported: Asp57frameshift (171insA) and Ile184Arg in IFNA17, Cys20Stop in IFNA10, and Tyr51Tyr (153 C-T) in IFNB1. 39, 40 Four nsSNPs reported in dbSNP were not present in the Hutterite screening set. These included one each in IFNA1 (rs2230050; freq. 0.031), IFNA8 (rs3739630; freq. 0.055), IFNA21 (rs3750478; freq. 0.036), and IFNW1 (rs2230055; freq. 0.007). To confirm that these variants were not present in the Hutterites, we re-sequenced in an expanded screening set of 36 individuals, the exons of the three genes with nsSNPs at 40.01 frequency in dbSNP. None of the three nsSNPs (nor an additional synonomous SNP in IFNA21; rs1053887, freq. 0.033) were present in the Hutterites (total of 96 chromosomes). Thus, consistent with a previous study in the Hutterites, 41 many SNPs that occur at frequencies o0.10 in the general population are absent in the Hutterites. dbSNP also reports four common nsSNPs (40.10 frequency) in IFNA4 (rs3750380, rs16938291, rs16938289, rs1062571), an exon that we were unable to specifically amplify. Three of these SNPs coincide with nucleotide differences between IFNA4 and the closely related IFNA17 gene, raising the possibility that they are not true SNPs. Because of this possibility and because we were not able to design primers that were specific to this gene, we did not perform additional studies in IFNA4.
The 78 polymorphisms that were identified in the 12-person screening set formed 22 unique genotype patterns among the 12 subjects in our screening set (Figure 1 ). Even among individuals with the same IFNA-STRP genotypes (e.g. individuals 1-6, individuals 7-8, and individuals 10-12 in Figure 1) , the genotypes at many IFN loci differed, particularly with respect to polymorphisms proximal to IFNA2 and distal to IFNA16. Consistent with this, there was little LD (r 2 o0.30) between genes at the most proximal (IFNA1, IFNA8) and most distal (IFNW1, IFNB1) ends of the region and a cluster of high LD in the middle of the region between genes from IFNA2 to IFNA10, which included the IFNA-STRP (Figure 2 ). Of note is that the fsSNP and all but two rare nsSNPs were present only in four individuals in the screening set, all of whom also carried the IFN-STRP 150 bp allele (individuals 9-12; Figure 1 ).
Single variant analysis
Although we originally aimed to genotype one variant each in the upstream and downstream flanking sequences of each single exon gene, and all known variants in the exons, due to the high sequence homology between genes we could not always achieve this goal. In particular, we were not able to specifically amplify the exons of IFNA2, IFNA4, and IFNA7. In addition, although two SNPs were identified in the flanking regions of IFNA7, we were unable to genotype either, and we were able to genotype only one SNP each in IFNA14 and IFNA10. Lastly, we were unable to genotype two synonymous and six nsSNPs ( Figure 1 , Table S1 ). SNP24 (Cys20Stop) was present in only one individual (9 in Figure 1 ) in the screening set, but this subject carried one other unique SNP (SNP20), presumably on the same haplotype, that was genotyped in the larger sample; and SNP18 (Gln102Lys) was present in only one individual (6 in Figure 1 ) who also carried another unique SNP (SNP7) that was genotyped in the larger sample. Four other untyped nsSNPs were present only in individuals 10-12 (SNP30, Asp94His; SNP 31, Ile46Val; SNP 73, Val10Ala; SNP74, Ala4163Gly), who were also the only carriers of ten of the genotyped SNPs (SNP24, SNP38, SNP39, SNP40, SNP45, SNP50, SNP52, SNP54, SNP57, SNP62). Thus, these typed SNPs served as surrogates for the untyped nsSNPs in association studies. Overall, we genotyped 760 individuals in the Hutterite pedigree for 40 polymorphisms in 14 of the 15 IFN genes, including four exonic SNPs ( Table 2 ). The mean inter-marker distance was 9.4 kb between markers across the region and 4.7 kb between markers in the genes. All markers were in Hardy-Weinberg equilibrium (P40.05).
The results of association studies with the individual variants are shown in Table 3 . There was modest association (Po0.05) with asthma-and atopy-related phenotypes across the entire region. No single marker showed association with asthma (not shown), although the phenotypes 'possible asthma' and BHR showed some association with variants in genes spanning the cluster, but with the most significant associations with variants in the three genes just proximal to the IFNA-STRP. This is consistent with our earlier study, in which we reported an association between the IFNA-STRP and the phenotype 'possible asthma' (called 'loose asthma' in that study). The STRP remained the most significantly associated marker with the 'possible asthma' phenotype (Po0.01), suggesting that there is likely additional variation in this region that underlies the association with the IFNA-STRP or that haplotypes or multiple genes contribute to the association with asthma. None of the variants that tagged the haplotypes with nsSNPs or the fsSNP were associated with asthma, although SNP45 showed modest association with BHR.
In contrast, variation in genes in the distal portion of the region was more strongly associated with atopic phenotypes (Po0.01). SNP16 and SNP21 were associated with þ SPT to tree/pollen allergens and SNP4 was associated with þ SPT to mold and to cockroach allergens; only the association with SNP16 in IFNA21 remained significant after correcting for multiple comparisons. Other more modest associations with þ SPT to mold and cockroach allergens were present at loci spanning from IFNB1 to IFNA6, but not including the IFNA-STRP, suggesting that different variation in this region influences atopic and asthma phenotypes. The four SNPs (SNP27, SNP38, SNP45, and SNP52) that tagged the haplotypes with the nsSNPs and the fsSNPs showed modest association (0.054P40.01) with a number of atopic phenotypes, but were not among the most significant results.
Haplotype analysis: within genes To explore the possibility that unidentified variation on a haplotype confers susceptibility, we first examined associations with haplotypes comprised of variants within each of the genes (the single typed variant in IFNA10 was combined with IFNA16 variants and the Figure 1 and Table 2 . Mb distances from 9p-ter are shown on the diagonal.
Type I interferons and asthma and atopy A Chan et al single typed variant in IFNA14 was combined with IFNA17 variants for a total of 12 'genic' analyses). In this analysis, three 'genes' in the distal end of the cluster were associated with atopic phenotypes: IFNA16/10 and IFNB1 with þ SPT to cockroach allergens (P ¼ 0.0031 and 0.0056, respectively) and IFNA21 with þ SPT to tree/ pollen allergens (P ¼ 0.0086). IFNA21 haplotypes were also more modestly associated with þ SPT to mold allergens (P ¼ 0.012) and any allergen (P ¼ 0.028). None of the other genes were associated with any phenotype at Po0.05. Only the associations with IFNA16/10 remained significant after adjusting for multiple comparisons. The IFNA16/10 haplotypes included variants in two genes, two untyped nsSNPs in IFNA16, and a variant (SNP27) that tagged the haplotype with three nsSNPs and one fsSNP. Thus, similar to the single variant analysis, IFNA21 and IFNB1 were associated with atopic phenotypes and together with IFNA16/10 showed the most significant associations overall, and there were no significant associations with asthma phenotypes.
Haplotype analysis: between genes
We next examined haplotype combinations between all pairs of genes to determine if variation in multiple genes interacts to influence risk for asthma or atopy. Here, highly significant associations with both asthma and atopy phenotypes were observed, often between genes that show little or no LD (Figure 3 ). Eleven pairwise combinations of genes yielded 27 P-values o0.00055 and, therefore, remained significant after adjusting for multiple comparisons (Figure 3) . The 'genes' most associated in the single gene analyses, IFNA16/10, IFNA21, and IFNB1, were included in 7, 13, and 5 of the significant pairwise associations, respectively. Additionally, IFNA1 was included in 11, IFNA8 in six, and IFNW1 in five of the significant pairwise comparisons. Together, at least one of these six 'genes' is included in all of the significant pairwise combinations. The five genes with nsSNPs (IFNA1, IFNA17, IFNA16, IFNA10, IFNA21) were included in the most significant pairwise associations. The minor allele at each SNP is shown on the right; the percentage of individuals in whom genotypes were successfully assigned is shown in the last column. MAF, minor allele frequency; Mb, distance from p-ter; fs, frameshift. rs numbers are shown in Table S1 .
Type I interferons and asthma and atopy A Chan et al Some combinations of genes appeared to be phenotype-specific, whereas others are associated with multiple phenotypes. For example, IFNA1, which includes two untyped nsSNPs, in combination with genes throughout most of the cluster is very specifically associated with þ SPT to mold allergens, whereas combinations that 
IFNB ( 
IFNA4
(2)
IFNA14/17 AS, possible asthma; B, bronchial hyper-responsiveness; AN, þ SPT to one or more allergens; M, þ SPT to mold allergens; H, þ SPT to house dust mite allergens; C, þ SPT to cockroach allergens; T, þ SPT to tree or pollen allergens.
Type I interferons and asthma and atopy A Chan et al include the four most proximal genes, IFNA4, IFNA21, IFNAW, IFNAB, tend to be more associated with þ SPT to any allergen, house dust mite, cockroach, and/or tree/ pollen allergens. On the other hand, IFNA21 in combination with IFNA4 or IFNA16/10 is significantly associated with possible asthma or BHR as well as with þ SPT to any allergen and to HDM, cockroach allergens, or trees/ pollens, and combinations of haplotypes in IFNB1 and IFNA8 (genes located at opposite ends of the cluster) are significantly associated with possible asthma, and to þ SPT to any allergen, cockroach and tree/pollen.
Discussion
We report here for the first time the patterns of variation and LD in the type I IFN cluster on chromosome 9p21 and associations of asthma and atopy with variation in IFN genes spanning this 400 kb region. We screened B25 kb of DNA including the flanking regions of all 15 functional genes and the single coding exon in 12 of these genes, and identified 78 polymorphisms (72 SNPs, 6 in/ dels). The occurrence of one SNP every B330 bp is nearly identical to the average rate reported in a survey of 106 genes. 42 Curiously, despite the fact that these molecules have been implicated in multiple pathways that are critical in the development of immune-mediated diseases, 16 little is known about the specificity or regulation of individual genes encoding the type I IFNs. Although many of the functions of IFN-a and IFN-b overlap, responses to treatments with each indicate that differences exist. For example, IFN-b is used for the treatment of multiple sclerosis (MS) whereas IFN-a is more effective for treatment of chronic viral hepatitis, chronic myelogenous leukemia, ulcerative colitis, and steroid-resistant asthma. 16 The side effects of each treatment also differ, further suggesting functional specificities. In particular, IFN-a, but not IFN-b, therapy has been associated with the development of acute arthritis or pancreatitis, elevated levels of circulating complement, and glomerulonephritis. Moreover, the regulation and timing of expression of these genes may also impact their biological effects. In animal and cell culture models, the effects of type I IFNs are both concentration-and development-dependent. For example, IFN-a can induce type I diabetes in transgenic mice, 16 but spontaneous diabetes in non-obese diabetic mice was inhibited by IFN-a in a dose-dependent fashion. 43 The addition of IFN-b to T cell-dendritic cell (DC) co-cultures during DC maturation induced a type II IFN (IFN-g) response, but addition of IFN-b to the primary co-culture shifted the cells toward an IL-10 response and inhibited IFN-g production. 44 These data suggest that there is tight regulation of expression of the type I IFN genes and that functional differences exist between IFN-b and IFNa.
The results of our study further suggest that the type I IFN genes may also differ with respect to regulation, function, and impact on disease risk. Only four of the 14 genes studied were independently associated with risk for atopy (IFNA16/10, IFNA21, IFNB1). Other genes were associated with risk but nearly always only in combination with one of the above genes. The notable exception to this is the highly specific association of IFNA1 in combination with nearly all other genes with þ SPT to mold allergens. Whereas þ SPT to house dust mite and cockroach (and trees/pollens to some extent) tended to show associations with the same combinations of IFN genes, located mainly in the distal region of the cluster (IFNA4 to IFNB1), combinations of genes in the proximal end (IFNA1 to IFNA5) showed associations with þ SPT to mold. This pattern of association suggests that the genetics of the immune response to mold allergens differs from the genetics of the immune response to other allergens. While we do not know the exact mechanism for these differences, we note that other studies in the Hutterites have also identified associations that were highly specific to mold allergens. For example, þ SPT to mold allergens was specifically associated with polymorphisms in the integrin b3 gene, ITGB3, in the Hutterites and three outbred populations 45 and with polymorphisms in the IL13 gene in the Hutterites. 46 This study further suggests that one or more variants in the proximal end of the IFN cluster, which likely include variation in IFNA1 or variation in LD with IFNA1, also influences the immune response to inhaled mold allergens.
Surprisingly, only IFNB1 in combination with IFNA8, and IFNA21 in combination with IFNA16/10 or IFNA4, are associated with asthma or BHR, despite the fact that the original evidence for linkage in this region was with an asthma phenotype. It is also noteworthy that no associations were detected with a strict asthma phenotype, but rather with a fairly loose definition of asthma that included individuals with just symptoms or just BHR or both, as in our previous study. 12 Although it is likely that some Hutterites with BHR who did not recall symptoms and some of the symptomatic Hutterites who did not have a 20% fall in baseline FEV 1 on the day of our testing do, in fact, have asthma, it is interesting that the strongest associations were with a fairly unconventional definition of asthma. Moreover, these same pairs of genes were also associated with atopy phenotypes. Thus, we suggest that these 'asthma' phenotypes are merely expressions of a general immune dysregulation that is common to asthma/allergy symptoms and BHR, and that genetic variation in the IFN genes influence this general immune response.
Overall, these results implicate for the first time genetic variation in the IFN gene cluster with Th2-mediated diseases, whereas prior studies of a limited number of IFN variants have reported associations with Th1-mediated diseases, MS 40 and sarcoidosis. 47 Although we cannot exclude the possibility that some of these associations are due to typed or untyped coding variation, we note that the coding variation in the Hutterites appears to be confined to one or a few haplotypes. Markers that tag these haplotypes, as well as the typed Asp57fs and Ile184Arg variants in IFNA17, were not strongly associated with any phenotypes in the single variant analysis, although most were infrequent (B0.06) in the Hutterites and, as a result, our power to detect associations with these SNPs was limited. The exception to this is the variant tagging the haplotype with the Cys20Stop variant in IFNA10. This tag SNP (SNP20) occurs at frequency 0.11 but was not associated with asthma or atopy in the single variant analysis, suggesting that this nonsense mutation does not by itself account for the observed associations. Taken together, our results do not provide evidence for coding variation per se accounting for the associations with atopy or asthma, although this possibility cannot be ruled out.
On the other hand, variation in noncoding sequences may influence the differential regulation and expression levels of the IFN-a and b products. In fact, a recent study of two coding variants in IFN genes in Japanese sarcoidosis patients reported an association with a haplotype comprised of the IFNA10 Cys60Stop and IFNA17 Ile184Arg SNPs (SNP24 and SNP35, respectively, in our study). 48 Despite the fact that the association was with two coding polymorphisms, cells from individuals with different haplotype combinations showed different expression levels of IFN-a protein, with the high IFN-aproducing haplotype associated with increased risk for sarcoidosis, consistent with the disease resulting from a Th1-mediated mechanism. 47 This result was interpreted as evidence for the presence of additional variation on the associated haplotype that influences transcription or expression of IFN genes. Our study, which implicates noncoding variation in the IFN gene cluster in risk for Th2-mediated diseases, is consistent with the suggestion that disease-associated variation affects expression levels of one or more genes.
The fact that the most significant associations were with combinations of genes, often between genes that show little or no LD, further suggests that these genes may interact to influence disease course or pathogenesis. Although we were unable to attribute differences in risk of developing asthma or atopy to specific variants, polymorphisms in five genes, IFNA1, IFNA16, IFNA10, IFNA21 and IFNB1, accounted for nearly all of the significant associations with atopy. IFNA8, IFNA2, and IFNA4 in combination with one or more of those five genes also showed significant associations with asthma. It is possible that variation in all eight genes influences IFN expression or function; comprehensive studies of variation in these genes in additional patient populations could help to refine the associations to fewer genes or variants. Finally, functional studies of the associated noncoding variation could reveal which variants directly influence expression levels and disease risk. Regardless, our study identifies a new family of candidate genes for asthma/atopy association studies, for studies of the relationship between viral infections and the development or exacerbation of asthma, 49, 50 and for pharmacogenetic studies of the differential response to IFN-a therapy in corticosteroid-resistant asthma and other atopic diseases. [27] [28] [29] [30] 
